Back
CytomX Therapeutics Stock Price Chart
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
Sell
38
CTMX
CytomX Therapeutics
Last Price:
$1.08
Seasonality Move:
-0.08%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTMX is experiencing slight buying pressure.
CytomX Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.11 | Sell |
| 20-day SMA: | 1.13 | Sell |
| 50-day SMA: | 1.06 | Buy |
| 200-day SMA: | 1.51 | Sell |
| 8-day EMA: | 1.11 | Sell |
| 20-day EMA: | 1.1 | Sell |
| 50-day EMA: | 1.1 | Sell |
| 200-day EMA: | 1.34 | Sell |
CytomX Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 49.29 | Sell |
| Chaikin Money Flow: | 603304 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.96 - 1.2) | Buy |
| Bollinger Bands (100): | (1.03 - 1.23) | Sell |
CytomX Therapeutics Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CytomX Therapeutics Stock
Is CytomX Therapeutics Stock a Buy?
-
CytomX Therapeutics share price is 1.09 while CTMX 8-day simple moving average is 1.11, which is a Sell signal.
-
The stock price of CTMX is 1.09 while CytomX Therapeutics 20-day SMA is 1.13, which makes it a Sell.
-
CytomX Therapeutics 50-day simple moving average is 1.06 while CTMX share price is 1.09, making it a Buy technically.
-
CTMX stock price is 1.09 and CytomX Therapeutics 200-day simple moving average is 1.51, creating a Sell signal.
CTMX Technical Analysis vs Fundamental Analysis
Sell
38
CytomX Therapeutics (CTMX)
is a Sell
Is CytomX Therapeutics a Buy or a Sell?
-
CytomX Therapeutics stock is rated a SellThe current CytomX Therapeutics [CTMX] share price is $1.09. The Score for CTMX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
CytomX Therapeutics Stock Info
Market Cap:
85.3M
Price in USD:
1.09
Share Volume:
1.3M
CytomX Therapeutics 52-Week Range
52-Week High:
5.85
52-Week Low:
0.83
Sell
38
CytomX Therapeutics (CTMX)
is a Sell
CytomX Therapeutics Share Price Forecast
-
What is the CytomX Therapeutics stock price today?The CytomX Therapeutics stock price is 1.09 USD today.
-
Will CTMX stock go up or go down?CytomX Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is CytomX Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, CytomX Therapeutics is overvalued.
Is CytomX Therapeutics Stock a Buy?
-
CytomX Therapeutics share price is 1.09 while CTMX 8-day exponential moving average is 1.11, which is a Sell signal.
-
The stock price of CTMX is 1.09 while CytomX Therapeutics 20-day EMA is 1.10, which makes it a Sell.
-
CytomX Therapeutics 50-day exponential moving average is 1.10 while CTMX share price is 1.09, making it a Sell technically.
-
CTMX stock price is 1.09 and CytomX Therapeutics 200-day simple moving average is 1.34, creating a Sell signal.
Fundamental Analysis of CytomX Therapeutics
Is CytomX Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.44 per share.
Technical Analysis of CytomX Therapeutics
Should I short CytomX Therapeutics stock?
-
CTMX Moving Average Covergence Divergence (MACD) indicator is 0.01, suggesting CytomX Therapeutics is a Buy
-
CytomX Therapeutics Relative Strength Index (RSI) is 49.29, which suggest CytomX Therapeutics is oversold
-
The Bollinger Bands (25) for CytomX Therapeutics is (0.96 - 1.2), which suggest CytomX Therapeutics is a Sell
-
The Bollinger Bands (100) for CytomX Therapeutics is (1.03 - 1.23), which suggest CytomX Therapeutics is a Sell
* CytomX Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.